日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

CD44v, S1PR1, HER3, MET and cancer-associated amino acid transporters are promising targets for the pancreatic cancers characterized using mAb.

CD44v、S1PR1、HER3、MET 和癌症相关氨基酸转运体是使用 mAb 表征的胰腺癌的有希望的靶点

期刊:FEBS Open Bio
影响因子:2.3
doi:10.1002/2211-5463.13963
Nakano Takashi, Okita Kouki, Okazaki Shogo, Yoshimoto Soshi, Masuko Sachiko, Yagi Hideki, Kato Kazunori, Tomioka Yoshihisa, Imai Kenichi, Hamada Yoichi, Masuko Kazue, Shimada-Takaura Kayoko, Nagai Noriaki, Saya Hideyuki, Arai Tomio, Ishiwata Toshiyuki, Masuko Takashi
肿瘤
胰腺癌
CD4
CD44
发表日期：2025
文献求助 收藏

HER4 and EGFR Activate Cell Signaling in NRG1 Fusion-Driven Cancers: Implications for HER2-HER3-specific Versus Pan-HER Targeting Strategies

HER4 和 EGFR 激活 NRG1 融合驱动癌症中的细胞信号传导：对 HER2-HER3 特异性靶向与泛 HER 靶向策略的启示

期刊:Journal of Thoracic Oncology
影响因子:20.8
doi:10.1016/j.jtho.2023.08.034
Udagawa, Hibiki; Nilsson, Monique B; Robichaux, Jacqulyne P; He, Junqin; Poteete, Alissa; Jiang, Hong; Heeke, Simon; Elamin, Yasir Y; Shibata, Yuji; Matsumoto, Shingo; Yoh, Kiyotaka; Okazaki, Shogo; Masuko, Takashi; Odintsov, Igor; Somwar, Romel; Ladanyi, Marc; Goto, Koichi; Heymach, John V
肿瘤
HER2
肿瘤免疫
信号转导
EGF
EGFR
细胞生物学
发表日期：2024
文献求助 收藏

Complete Cure of Inoperable Stage IV Locally Advanced Hypopharyngeal Squamous Cell Carcinoma by an Innovative Combination Cancer Immunotherapy Consisting of Radiation, Immune Checkpoint Inhibitors, and Dendritic Cell Vaccine

通过由放射疗法、免疫检查点抑制剂和树突状细胞疫苗组成的创新性联合癌症免疫疗法，彻底治愈了无法手术的IV期局部晚期下咽鳞状细胞癌。

期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.69429
Iwasaki, Takanori; Yazaki, Yuichiro; Myojo, Tomohiro; Masuko, Takashi; Nishimura, Takashi
Checkpoint
肿瘤
肿瘤免疫
树突状细胞
细胞生物学
树突状细胞
免疫/内分泌
发表日期：2024
文献求助 收藏

Genetic manipulation resulting in decreased donor chondroitin sulfate synthesis mitigates hepatic GVHD via suppression of T cell activity

基因操作导致供体硫酸软骨素合成减少，通过抑制 T 细胞活性来减轻肝 GVHD

期刊:Scientific Reports
影响因子:3.8
doi:10.1038/s41598-023-40367-3
Suguru Tamura, Hajime Ishiguro, Tatsuya Suwabe, Takayuki Katagiri, Kaori Cho, Kyoko Fuse, Yasuhiko Shibasaki, Tadahisa Mikami, Takero Shindo, Hiroshi Kitagawa, Michihiro Igarashi, Hirohito Sone, Masayoshi Masuko, Takashi Ushiki
细胞生物学
T细胞
发表日期：2023
文献求助 收藏

Dual-targeting therapy against HER3/MET in human colorectal cancers

针对人类结直肠癌中 HER3/MET 的双靶点治疗

期刊:Cancer Medicine
影响因子:2.9
doi:10.1002/cam4.5673
Akitaka Yamasaki,Rikuto Miyake,Yuta Hara,Hideki Okuno,Takuya Imaida,Kouki Okita,Shogo Okazaki,Yasutoshi Akiyama,Kenji Hirotani,Yuichi Endo,Kazue Masuko,Takashi Masuko,Yoshihisa Tomioka
肠癌
Human
肿瘤
MET
发表日期：2023
文献求助 收藏

CD98 regulates the phosphorylation of HER2 and a bispecific anti-HER2/CD98 antibody inhibits the growth signal of human breast cancer cells

CD98 调节 HER2 的磷酸化，双特异性抗 HER2/CD98 抗体抑制人乳腺癌细胞的生长信号

期刊:Genes to Cells
影响因子:1.3
doi:10.1111/gtc.13016
Akitaka Yamasaki, Kumiko Maruyama-Takahashi, Kento Nishida, Shogo Okazaki, Kouki Okita, Yasutoshi Akiyama, Hideaki Suzuki, Yuichi Endo, Kazue Masuko, Takashi Masuko, Yoshihisa Tomioka
信号转导
肿瘤
表观遗传
乳腺癌
肿瘤细胞
Human
发表日期：2023
文献求助 收藏

Oncogenic transformation of NIH/3T3 cells by the overexpression of L-type amino acid transporter 1, a promising anti-cancer target

NIH/3T3 细胞通过 L 型氨基酸转运蛋白 1 的过度表达发生致癌转化，这是一种很有前途的抗癌靶点

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.27981
Natsumi Hayashi, Akitaka Yamasaki, Shiho Ueda, Shogo Okazaki, Yoshiya Ohno, Toshiyuki Tanaka, Yuichi Endo, Yoshihisa Tomioka, Kazue Masuko, Takashi Masuko, Reiko Sugiura
肿瘤
其它细胞
Donkey
IgG
发表日期：2021
文献求助 收藏

Anti-tumor effects of an antagonistic mAb against the ASCT2 amino acid transporter on KRAS-mutated human colorectal cancer cells

拮抗ASCT2氨基酸转运蛋白的单克隆抗体对KRAS突变型人结直肠癌细胞的抗肿瘤作用

期刊:Cancer Medicine
影响因子:2.9
doi:10.1002/cam4.2689
Yuta Hara,Yushi Minami,Soshi Yoshimoto,Natsumi Hayashi,Akitaka Yamasaki,Shiho Ueda,Kazue Masuko,Takashi Masuko
肠癌
Human
细胞生物学
肿瘤
ASC
ASCT2
RAS
发表日期：2020
文献求助 收藏

Novel functional anti-HER3 monoclonal antibodies with potent anti-cancer effects on various human epithelial cancers

新型功能性抗HER3单克隆抗体对多种人类上皮癌具有强效抗癌作用

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.27414
Okita, Kouki; Okazaki, Shogo; Uejima, Shinya; Yamada, Erina; Kaminaka, Hiroki; Kondo, Misa; Ueda, Shiho; Tokiwa, Ryo; Iwata, Nami; Yamasaki, Akitaka; Hayashi, Natsumi; Ogura, Dai; Hirotani, Kenji; Yoshioka, Toshiaki; Inoue, Masahiro; Masuko, Kazue; Masuko, Takashi
单克隆抗体
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

Anti-tumor effects of mAb against L-type amino acid transporter 1 (LAT1) bound to human and monkey LAT1 with dual avidity modes

以双重亲和力模式与人类和猴 LAT1 结合的针对 L 型氨基酸转运蛋白 1 (LAT1) 的 mAb 的抗肿瘤作用

期刊:Cancer Science
影响因子:4.5
doi:10.1111/cas.13908
Shiho Ueda, Hidemi Hayashi, Takako Miyamoto, Shinya Abe, Kana Hirai, Kanji Matsukura, Hideki Yagi, Yuta Hara, Kinji Yoshida, Shogo Okazaki, Masakazu Tamura, Yuki Abe, Toshinori Agatsuma, Shin-Ichiro Niwa, Kazue Masuko, Takashi Masuko
肿瘤
Human
发表日期：2019
文献求助 收藏